AH

Albert Hansen

Island Pharmaceuticals Limited | Non-Executive Director
Mr Hansen has over 30 years of private equity investment experience, with almost 20 years in the life sciences/pharmaceutical field. He is a former Chairman and interim CEO of Questcor Pharmaceuticals, Inc (later acquired for US$5 billion), a former Chairman and interim CEO of Cedarburg Pharmaceuticals Inc. (acquired for US$40 million) and former Chairman of Molecular Medicine Corporation (acquired for US$24 million). KESA Partners, Inc acquired a failing company, Bioserv Corporation, for US$25,000 from NextPharma, Ltd in November 2012.

Company and Role

Company
Title
Tenure
Since
ILA
ILA
Island Pharmaceuticals Limited
  • Non-Executive Director
4yrs, 2mthOct 2020

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ILA
ILA
Island Pharmaceuticals Limited
30/06/24N/A11,104,034166,667N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ILA
ILA
Island Pharmaceuticals Limited
30/04/24
Expiry
400,000$0.053$21,200Options expired
ILA
ILA
Island Pharmaceuticals Limited
26/03/24
Issued
166,667$0.060$10,000Rights issue
ILA
ILA
Island Pharmaceuticals Limited
26/03/24
Issued
166,667$0.060$10,000Rights issue
ILA
ILA
Island Pharmaceuticals Limited
04/04/23
Expiry
23,030$0.070$1,612Options expired
ILA
ILA
Island Pharmaceuticals Limited
18/11/21
Issued
100,000$0.250$25,000Director remuneration